Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
SV Health Investors
Biotech
Artios Pharma widens clinical ambitions with $115M series D
The biotech will use the funds to extend its clinical ambitions for its pipeline of DNA-damage-response-inhibiting cancer prospects.
Zoey Becker
Nov 17, 2025 8:00am
Neuro-focused Draig hatches with red-hot $140M series A
Jun 18, 2025 12:01am
Pharma-backed dementia fund raises $269M to invest in therapies
May 20, 2025 9:48am
Investment firm secures $250M to help fund dementia drug R&D
Mar 20, 2025 2:53pm
Sanofi plucks new CSO from in-stealth biotech
Sep 24, 2024 10:44am
J&J, Google back inflammatory disease startup Mestag with $45M
Aug 3, 2021 12:18pm
